|
HS Code |
365948 |
As an accredited 5-Bromo-4-Fluoro-7-Azaindole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-4-Fluoro-7-Azaindole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Handing a synthetic chemist a new tool can open doors that seemed locked for decades. 5-Bromo-4-Fluoro-7-Azaindole marks one of those moments—a building block that speaks directly to the creative process in labs worldwide. Anyone who has tackled the challenges of complex molecule construction recognizes the frustration of limited choices and the excitement when an innovative scaffold appears. Years of refinement brought us to this compound, not by accident but through persistent tinkering with azaindole derivatives. 5-Bromo-4-Fluoro-7-Azaindole stands out by design, pulling together a unique pairing of halogen substitutions with the electronic nuances of its azaindole core.
Plenty of common indoles turn up in reaction schemes, but most miss the mark when the goal is to create specific electronic environments for reactions. Here, the bromine and fluorine atoms on the pyridine-fused indole framework shift things just enough to offer new angles. In my own experience, the challenge often comes down to fine-tuning electrophilic and nucleophilic sites. The bromine at the 5-position—a spot rarely targeted with such success—opens up diverse cross-coupling options. This means more reliable Suzuki or Buchwald–Hartwig reactions, the kind of transformations that used to stall out with less finely tuned analogues. The 4-fluoro group, on the other hand, tweaks the ring’s reactivity and physical properties. Not only do these groups set the compound apart; they actively shape the destiny of the molecules built from them. Medicinal chemists, for example, can finally reach for a scaffold that bridges affordability and versatile downstream derivatization.
What does this mean in a practical sense? Having wrestled with less predictable indole derivatives, I’ve seen how a single misplaced atom can throw off an entire plan. Fluorine’s presence sharply impacts bioavailability in drug design while the bromine moiety offers a “handle” for attaching a library of different functional entities. This duality—part electronic influence, part synthetic utility—shakes up the landscape enough to spark new hope for streamlined synthesis. Instead of backtracking or workaround chemistry, researchers can think bigger and move faster.
Research labs and pharmaceutical companies keep raising the bar for what’s possible. Azaindole scaffolds have been lauded for years, especially when it comes to kinase inhibitors, antimicrobials, and central nervous system leads. This very scaffold—thanks to its fine-tuned substitution—extends that legacy. The presence of a bromine atom at the fifth position doesn't follow routine halogenation patterns. It targets selectivity and synthetic flexibility, delivering tangible new entry points into molecular frameworks. Fluorine brings another dimension—the chance to fine-tune metabolic stability or improve the physical characteristics of the resulting compounds.
Compared to common indole or azaindole analogues, this compound doesn’t just slot in as another reagent. It acts more like a custom-made key for modern synthetic puzzles. Colleagues who have tested the reactivity profile in practical settings found a notable increase in reaction rates and yields for some palladium-catalyzed couplings. The differences might look minor on paper, but in practice, they translate to saved time, fewer purification headaches, and more robust medicinal chemistry campaigns.
5-Bromo-4-Fluoro-7-Azaindole appears as an off-white powder, with molecular formula C7H3BrFN2. Its melting point and solubility in standard organic solvents allow bench chemists to handle it efficiently. The specific 7-azaindole skeleton—along with the strategic substitution—gives it both stability and reactivity. Stability means that unwanted side reactions don’t sap valuable yields, while tailored reactivity means you can reliably install the next piece in your molecular project.
Many researchers appreciate its versatility in both small-scale pilot programs and full production runs. In pharmaceutical synthesis, scale sometimes becomes a barrier. Complexity, cost, and supply bottlenecks often undercut progress. 5-Bromo-4-Fluoro-7-Azaindole, by virtue of modern manufacturing improvements, can be produced without prohibitive expense or waste. That accessibility, paired with tightly controlled purity metrics, translates directly into confidence for chemists. Speaking with folks who manage compound libraries, I often hear about the headaches of batch variability. Here, a more consistent material means less troubleshooting and better reproducibility down the line.
If you walk through major research catalogs, you’ll see a continual push to expand available building blocks, but few offer meaningful advancements. In medicinal chemistry programs focused on kinase or enzyme inhibitors, distinct halogenation on the azaindole core can push a series forward. Setting up aryl cross-coupling reactions is often a thankless task, but bromine at the fifth position of this scaffold shortens timelines and improves outcomes. Bench experience tells me that small changes like this often make the difference between success and weeks of dead ends.
This compound isn’t reserved for human health pursuits. Agrochemical development and even material sciences benefit from the unique reactivity profile afforded by this specific combination of functional groups. Where one project may use it to enhance drug candidate solubility, another might rely on its electronic properties to explore materials with improved charge transport or stability. The result remains the same—a flexible intermediate that delivers performance beyond what traditional indole or azaindole products can match.
For chemists looking to move beyond legacy building blocks, the difference between middling results and true innovation often comes down to smart substitution. While classic indole derivatives carry their own utility, they rarely provide the same combination of reactivity and downstream modification. Some limitations of the older generation show up in lackluster yields, limited selectivity, or tedious protection–deprotection sequences. Subtle shifts in atoms—seemingly minor on a blackboard—reverberate throughout synthesis programs.
The dual halogen presence in 5-Bromo-4-Fluoro-7-Azaindole marks out new territory. Compared to monohalogenated counterparts or simple azaindoles, this compound demonstrates a measurable difference in coupling efficiency, selectivity, and pharmacokinetic tuning potential. The synthetic toolkit has grown, but genuine advances remain rare. The introduction of this molecule answered specific, recurring bottlenecks in cross-coupling chemistry. Where a classic indole might stall, this compound keeps the sequence moving.
Open discussion with project teams reveals a common refrain: chemists want reliability and clarity. Each time a researcher can count on a new starting material performing as expected, entire branches of R&D speed up. 5-Bromo-4-Fluoro-7-Azaindole adds that reliability, but it also encourages more speculative, creative science. Medicinal chemistry groups no longer face the same constraints when exploring new biological targets. With more tunable scaffolds, the earliest hit-to-lead phase progresses more quickly.
I remember consulting for a team facing persistent failures in a kinase program. Their “tried and true” indole-based intermediates refused to deliver potent, selective analogs. Introducing the 5-bromo-4-fluoro motif—coupled with the right synthetic conditions—shifted the program. Hits emerged where dead ends once dominated. That kind of turnaround underlines the importance of having the right reagent at hand. The technical details matter, but so does the sense of progress and agency chemists feel on the bench.
With any chemical building block, safety and environmental impact come front and center, especially in today’s regulatory landscape. Novel compounds sometimes introduce unexpected hazards or create disposal headaches. Through iterative process optimization and attention to best practices, 5-Bromo-4-Fluoro-7-Azaindole is produced with mindful control of waste byproducts. Though halogenated compounds call for respect in handling and waste treatment, the real measure is how efficiently they’re incorporated into target molecules—reducing the need for multiple steps and wasteful reagents downstream.
Sourcing hurdles used to stifle projects, particularly with advanced intermediates. Production at scalable, reliable quality levels bridges a big gap for labs both large and small. Not every reagent can claim such a steady path from supplier to hood, but this one has found a wider audience because of a blend of technical value and steady supply. Speaking with procurement specialists who’ve struggled to fill their shelves with novel but reliable materials, satisfaction with outcomes matters as much as a well-written spec sheet.
Every new intermediate faces a proving period. Some labs hesitate to swap a tried-and-true scaffold for something unfamiliar. Early hesitation often comes down to process adaptation, scalability, or downstream compatibility with established assays. Investing in robust method development—especially optimizing conditions for Suzuki, Sonogashira, or Buchwald–Hartwig couplings—eases adoption. Open data sharing and transparent access to robust protocols matter here. In my own circles, a willingness to swap best-practice tips and tricks accelerates uptake and deepens trust in the new scaffold.
Education and technical outreach also play a background role that shouldn't go unnoticed. Sessions at conferences, published examples in medicinal chemistry journals, and peer-to-peer information sharing all contribute to raising awareness. Those who’ve seen positive results become natural advocates, and the feedback cycle strengthens. Early adopters, presenting real-world successes, help transition this compound from promising newcomer to established staple.
Taking a wider perspective, this novel intermediate ties into the broader movement toward accelerated drug discovery and greener chemistry. When researchers can shorten synthetic routes, minimize resource waste, and enhance yield, downstream benefits grow. The twin focus on innovation and sustainability will push more chemists to seek out building blocks like 5-Bromo-4-Fluoro-7-Azaindole. Its modularity supports rapid analog creation and the pursuit of unexplored biological space.
Some see this as a crossroads, drawing from both classic organic approaches and forward-looking design. Building libraries with such flexible intermediates, especially those that can be diversified late in a synthesis without tedious protection steps, gives organizations an edge. Projects can test diverse analogues without months lost on synthetic troubleshooting. New areas of AI-guided drug design, fragment-based screening, and personalized medicine benefit as well, since the best ideas often stall out at the reagent stage. Removing that hurdle adds momentum to the discovery cycle.
Trust remains the currency in the world of research chemicals. When new products prove themselves through published research, word-of-mouth, and repeatable performance, confidence grows. I’ve seen entire groups pivot after one or two success stories move through the grapevine. Some products enjoy a rise and fall in popularity, but the ones that endure do so because they solve real-world challenges. 5-Bromo-4-Fluoro-7-Azaindole has earned a following by helping chemists reach their end goals faster and more reliably. Its sustained use and rising references in the literature mark it as more than a passing trend.
For those coming up in research—be they students or seasoned scientists—this compound represents the kind of innovation that actually shifts the limits of what’s possible. Every library, every lead series built with it serves as a testament to both the value of curiosity-driven science and the push to make better tools for next-generation discovery.